Estrella Immunopharma, Inc. (ESLA) Insider Trading -- Recent Executive & Director Transactions

1 insiders reported 3 Form 4 transactions for Estrella Immunopharma, Inc. (ESLA) over the past 18 months (most recent 2026-04-29). Recent activity: Xu Jiandong (Chief Financial Officer) Buy 100 shares, Xu Jiandong (Chief Financial Officer) Buy 1,000 shares, Xu Jiandong (Chief Financial Officer) Buy 1,000 shares. Source: SEC Form 4.

DateInsiderTitleTypeSharesValue
2026-04-29Xu JiandongChief Financial OfficerBuy100$104
2026-04-29Xu JiandongChief Financial OfficerBuy1,000$1,160
2026-04-29Xu JiandongChief Financial OfficerBuy1,000$1,330

Source: SEC Form 4 filings · as of 2026-04-29